1. About the Company
Windlas Biotech operates as a leading CDMO player in India's generic pharmaceutical space. Founded in 2001 and listed in August 2021, with five WHO-GMP compliant manufacturing units in Dehradun.
2. Business Segments
Generic Formulations CDMO (73% of FY25 revenue): 5-year revenue CAGR of 14%, 99% product IP owned by Windlas, 757 customers and 5,582 brands.
